Yan Zhao - GFR Pharmaceuticals CEO and Director
CEO
Mr. Zhao Yan Ding is Chief Executive Officer and Director of GFR Pharmaceuticals Inc. since January 2008. He holds a masters degree as a senior engineer. He worked for Xian Herbal Medicine Company in the Administration and Marketing Department from 1997 to 2001 and gained the honor of advanced staff within two years. In 2001 he took a position with Xian Rising Biosep Biotechnique Co. Ltd. in the Researches Production Department. He also worked for Zhejiang Haikang BioProducts Co. Ltd to set up their bio research department within company. From 2003 to the present he has worked in Xian Biosep Biotechnique Co. Ltd. as their chief of research and the supervisor of the company. since 2008.
| Age | 37 |
| Tenure | 16 years |
Similar Executives
| Found 7 records | CEO Age | ||
| D Bristow | Barrick Gold Corp | 61 | |
| Ty Silberhorn | Apogee Enterprises | 56 | |
| Daniel OBrien | Flexible Solutions Internationa | 67 | |
| Mark Bristow | Barrick Gold Corp | 61 | |
| Stephen King | Dave Busters Entertainment | 59 | |
| Joseph Puishys | Apogee Enterprises | 59 | |
| James Dolan | Sphere Entertainment Co | 69 | |
GFR Pharmaceuticals Management Team
Elected by the shareholders, the GFR Pharmaceuticals' board of directors comprises two types of representatives: GFR Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of GFR. The board's role is to monitor GFR Pharmaceuticals' management team and ensure that shareholders' interests are well served. GFR Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, GFR Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
GFR Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is GFR Pharmaceuticals a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards GFR Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, GFR Pharmaceuticals' short interest history, or implied volatility extrapolated from GFR Pharmaceuticals options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Consideration for investing in GFR Pink Sheet
If you are still planning to invest in GFR Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the GFR Pharmaceuticals' history and understand the potential risks before investing.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |